Skip to main content
Top
Published in: Maternal and Child Health Journal 2/2013

01-02-2013

The Relationship Between Receiving Care Within a Medical Home and HPV Vaccine Receipt for Adolescent Girls: Results of the 2007 National Survey of Children’s Health

Authors: F. Sara Test, Rachel Caskey, Kristin M. Rankin

Published in: Maternal and Child Health Journal | Issue 2/2013

Login to get access

Abstract

To estimate initiation of HPV vaccination among adolescent girls and examine the relationship between receiving care consistent with the medical home model in a population-based sample. We used the National Survey of Children’s Health 2007, a nationally representative sample of children in the United States, to study adolescent girls 12–17 years of age. We present the results of descriptive and multivariable logistic regression analyses for the relationship between receiving care within a medical home, as defined by the American Academy of Pediatrics, and HPV vaccination initiation. Overall, 18.1% of adolescent girls had received at least one HPV vaccine injection and 54.6% received care within a medical home. The relationship between having a medical home and HPV vaccine initiation was heterogeneous across levels of household income and parent education. After adjusting for region of U.S., insurance status, and race/ethnicity, we found increased odds of HPV vaccine receipt for girls with versus without a medical home among those in low income households (<300% of the federal poverty level) whose parents have less than a high school education (OR 3.98, 95% CI 1.52–10.44). Results were not significant for other strata of household income and parent education. These findings suggest the important role of receiving care in a medical home model in HPV vaccine adoption for adolescents in households with low incomes and low parent education. Continued promotion of the medical home model at the federal and state levels, especially within vulnerable populations, may help to reduce disparities in access to preventive vaccines.
Literature
1.
go back to reference Myers, E. R., McCrory, D. C., Nanda, K., et al. (2000). Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. American Journal of Epidemiology, 151(12), 1158–1171.PubMedCrossRef Myers, E. R., McCrory, D. C., Nanda, K., et al. (2000). Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. American Journal of Epidemiology, 151(12), 1158–1171.PubMedCrossRef
2.
go back to reference Forhan, S. E., Gottlieb, S. L., Strenberg, M. R., et al. (2009). Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics, 124(6), 1505–1512.PubMedCrossRef Forhan, S. E., Gottlieb, S. L., Strenberg, M. R., et al. (2009). Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics, 124(6), 1505–1512.PubMedCrossRef
3.
go back to reference Dunne, E. F., Unger, E. R., Sternberg, G., et al. (2007). Prevalence of HPV infection among females in the United States. JAMA, 297(8), 813–819.PubMedCrossRef Dunne, E. F., Unger, E. R., Sternberg, G., et al. (2007). Prevalence of HPV infection among females in the United States. JAMA, 297(8), 813–819.PubMedCrossRef
4.
go back to reference Brewer, N., Gottlieb, S., & Reiter, P. (2010). Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sexually transmitted diseases, 37(12),197-204.PubMed Brewer, N., Gottlieb, S., & Reiter, P. (2010). Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sexually transmitted diseases, 37(12),197-204.PubMed
5.
go back to reference Garland, S. M., Hernandez-Avila, A., Wheeler, C. M., et al. (2007). Quadrivalence vaccine against human papillomavirus to prevent anogenital diseases. New England Journal of Medicine, 356(19), 1928–1943.PubMedCrossRef Garland, S. M., Hernandez-Avila, A., Wheeler, C. M., et al. (2007). Quadrivalence vaccine against human papillomavirus to prevent anogenital diseases. New England Journal of Medicine, 356(19), 1928–1943.PubMedCrossRef
6.
go back to reference Downs, L., Scarinci, I., Einstein, M., et al. (2010). Overcoming the barriers to HPV vaccination in high-risk populations in the US. Gynecologic Oncology, 117, 486–490.PubMedCrossRef Downs, L., Scarinci, I., Einstein, M., et al. (2010). Overcoming the barriers to HPV vaccination in high-risk populations in the US. Gynecologic Oncology, 117, 486–490.PubMedCrossRef
7.
go back to reference Centers for Disease Control and Prevention. (2007). Quadrivalent human papillomavirus vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report, 56(early release):1–24. Centers for Disease Control and Prevention. (2007). Quadrivalent human papillomavirus vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report, 56(early release):1–24.
8.
go back to reference Caskey, R., Lindau, S., & Alexander, G. (2009). Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. Journal of Adolescent Health, 45, 453–462.PubMedCrossRef Caskey, R., Lindau, S., & Alexander, G. (2009). Knowledge and early adoption of the HPV vaccine among girls and young women: Results of a national survey. Journal of Adolescent Health, 45, 453–462.PubMedCrossRef
9.
go back to reference Centers for Disease Control and Prevention. (2008). Vaccination coverage among adolescents aged 13–17 years—United States 2007. MMWR Morbidity and Mortality Weekly Report, 57(50), 1100–1103. Centers for Disease Control and Prevention. (2008). Vaccination coverage among adolescents aged 13–17 years—United States 2007. MMWR Morbidity and Mortality Weekly Report, 57(50), 1100–1103.
10.
go back to reference Centers for Disease Control and Prevention. (2009). Vaccination coverage among adolescents aged 13–17 years—United States 2008. MMWR Morbidity and Mortality Weekly Report, 58(36), 997–1001. Centers for Disease Control and Prevention. (2009). Vaccination coverage among adolescents aged 13–17 years—United States 2008. MMWR Morbidity and Mortality Weekly Report, 58(36), 997–1001.
11.
go back to reference Centers for Disease Control and Prevention. (2011). Vaccination coverage among adolescents aged 13–17 years—United States 2010. MMWR Morbidity and Mortality Weekly Report, 60(33), 1117–1123. Centers for Disease Control and Prevention. (2011). Vaccination coverage among adolescents aged 13–17 years—United States 2010. MMWR Morbidity and Mortality Weekly Report, 60(33), 1117–1123.
12.
go back to reference Rosenthal, S., Rupp, R., Zimet, G., et al. (2008). Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes. Journal of Adolescent Health, 43, 239–245.PubMedCrossRef Rosenthal, S., Rupp, R., Zimet, G., et al. (2008). Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes. Journal of Adolescent Health, 43, 239–245.PubMedCrossRef
13.
go back to reference Pruitt, S., & Schootman, M. (2010). Geographic disparity, area poverty, and human papillomavirus vaccination. American Journal of Preventive Medicine, 38(5), 525–533.PubMedCrossRef Pruitt, S., & Schootman, M. (2010). Geographic disparity, area poverty, and human papillomavirus vaccination. American Journal of Preventive Medicine, 38(5), 525–533.PubMedCrossRef
14.
go back to reference Chao, C., Velicer, C., Slezak, J., et al. (2010). Correlates for Human Papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology, 171(3), 357–367.PubMedCrossRef Chao, C., Velicer, C., Slezak, J., et al. (2010). Correlates for Human Papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology, 171(3), 357–367.PubMedCrossRef
15.
go back to reference Rosenthal, S. L., Weiss, T. W., Zimet, G. D., et al. (2011). Predictors of HPV vaccine uptake among women aged 19–26: Importance of physician’s recommendation. Vaccine, 29(5), 890–895.PubMedCrossRef Rosenthal, S. L., Weiss, T. W., Zimet, G. D., et al. (2011). Predictors of HPV vaccine uptake among women aged 19–26: Importance of physician’s recommendation. Vaccine, 29(5), 890–895.PubMedCrossRef
16.
go back to reference Guerry, S. L., De Rosa, C. J., Markowitz, L. E., et al. (2011). Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine, 29(12), 2235–2241.PubMedCrossRef Guerry, S. L., De Rosa, C. J., Markowitz, L. E., et al. (2011). Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine, 29(12), 2235–2241.PubMedCrossRef
17.
go back to reference Dorell, C. G., Yankey, D., Santibanez, T. A., et al. (2011). Human papillomavirus vaccination series initiation and completion, 2008–2009. Pediatrics, 128(5), 830–839.PubMedCrossRef Dorell, C. G., Yankey, D., Santibanez, T. A., et al. (2011). Human papillomavirus vaccination series initiation and completion, 2008–2009. Pediatrics, 128(5), 830–839.PubMedCrossRef
18.
go back to reference Jain, N., Euler, G., Shefer, A., et al. (2009). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Preventive Medicine, 48, 426–431.PubMedCrossRef Jain, N., Euler, G., Shefer, A., et al. (2009). Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Preventive Medicine, 48, 426–431.PubMedCrossRef
19.
go back to reference Conroy, K., Rosenthal, S. L., Zimet, G. D., et al. (2009). Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of Womens Health, 18(10), 1679–1686.CrossRef Conroy, K., Rosenthal, S. L., Zimet, G. D., et al. (2009). Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. Journal of Womens Health, 18(10), 1679–1686.CrossRef
20.
go back to reference American Academy of Pediatrics. (2002). Medical home initiatives for children with special needs project advisory committee, the medical home. Pediatrics, 110(1), 184–186.CrossRef American Academy of Pediatrics. (2002). Medical home initiatives for children with special needs project advisory committee, the medical home. Pediatrics, 110(1), 184–186.CrossRef
21.
go back to reference Homer, C., Klatka, K., Kublthau, K., et al. (2008). A review of the evidence for the medical home for children with special health care needs. Pediatrics, 122(4), e922–e937.PubMedCrossRef Homer, C., Klatka, K., Kublthau, K., et al. (2008). A review of the evidence for the medical home for children with special health care needs. Pediatrics, 122(4), e922–e937.PubMedCrossRef
23.
go back to reference The Child and Adolescent Health Measurement Initiative. (2009). Measuring medical home for children and youth: Methods and findings from the National Survey of Children with Special Health Care Needs and the National Survey of Children’s Health. Available at http://medicalhomedata.org/content/Default.aspx. The Child and Adolescent Health Measurement Initiative. (2009). Measuring medical home for children and youth: Methods and findings from the National Survey of Children with Special Health Care Needs and the National Survey of Children’s Health. Available at http://​medicalhomedata.​org/​content/​Default.​aspx.
24.
go back to reference Saslow, D. & Wheeler, C. (2007). Human papillomavirus vaccines: Who will pay, who will receive, when to administer? Ethnicity & Disease, 17:S2-8–S2-13. Saslow, D. & Wheeler, C. (2007). Human papillomavirus vaccines: Who will pay, who will receive, when to administer? Ethnicity & Disease, 17:S2-8–S2-13.
25.
go back to reference Christakis, D. A., Wright, J. A., & Zimmerman, F. J., et al. (2002). Continuity of care is associated with high-quality care by parent report. Pediatrics, 109(4):e54. Christakis, D. A., Wright, J. A., & Zimmerman, F. J., et al. (2002). Continuity of care is associated with high-quality care by parent report. Pediatrics, 109(4):e54.
26.
go back to reference Christakis, D. A., Wright, J. A., Koepsell, T. D., et al. (1999). Is greater continuity of care associated with less emergency department utilization? Pediatrics, 103(4), 738–742.PubMedCrossRef Christakis, D. A., Wright, J. A., Koepsell, T. D., et al. (1999). Is greater continuity of care associated with less emergency department utilization? Pediatrics, 103(4), 738–742.PubMedCrossRef
27.
go back to reference Wang, C., Willa, M., Mulligan, D., et al. (2005). Cost and utilization analysis of a pediatric emergency department diversion project. Pediatrics, 116(5), 1075–1079.PubMedCrossRef Wang, C., Willa, M., Mulligan, D., et al. (2005). Cost and utilization analysis of a pediatric emergency department diversion project. Pediatrics, 116(5), 1075–1079.PubMedCrossRef
28.
go back to reference Strickland, B., McPerhson, M., Weissman, G., et al. (2004). Access to the medical home: Results of the National Survey of Children with special health care needs. Pediatrics, 113(5), 1485–1492.PubMed Strickland, B., McPerhson, M., Weissman, G., et al. (2004). Access to the medical home: Results of the National Survey of Children with special health care needs. Pediatrics, 113(5), 1485–1492.PubMed
Metadata
Title
The Relationship Between Receiving Care Within a Medical Home and HPV Vaccine Receipt for Adolescent Girls: Results of the 2007 National Survey of Children’s Health
Authors
F. Sara Test
Rachel Caskey
Kristin M. Rankin
Publication date
01-02-2013
Publisher
Springer US
Published in
Maternal and Child Health Journal / Issue 2/2013
Print ISSN: 1092-7875
Electronic ISSN: 1573-6628
DOI
https://doi.org/10.1007/s10995-012-0975-1

Other articles of this Issue 2/2013

Maternal and Child Health Journal 2/2013 Go to the issue